Dioxaborinine-styrylquinoline hybrids as multitarget small-molecule theranostic compounds against Alzheimer's disease.

Álvaro Sarabia-Vallejo; Mario Fuente-Tovar; José Clerigué; Pilar López-Alvarado; Chongzhao Ran; M Antonia Martín; J Carlos Menéndez

doi:10.1016/j.bioorg.2026.110475

SCHEDA SCIENTIFICA2026Altra ricerca

Dioxaborinine-styrylquinoline hybrids as multitarget small-molecule theranostic compounds against Alzheimer's disease.

Álvaro Sarabia-Vallejo, Mario Fuente-Tovar, José Clerigué, Pilar López-Alvarado, Chongzhao Ran, M Antonia Martín, J Carlos Menéndez

Bioorganic chemistry · 2026

Psicologia generale

Abstract e pubblicazione originale

L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.

Leggi nella fonte originale ↗

Parole chiave

Alzheimer DiseaseAnimalsQuinolinesHumansMiceAmyloid beta-Peptidestau ProteinsMolecular StructureStructure-Activity RelationshipFluorescent DyesOptical ImagingBoron CompoundsTheranostic NanomedicineDose-Response Relationship, DrugFluorescent probesProtein aggregationTau proteinTheranosticsΒ-Amyloid protein

Come citare questo studio

Álvaro Sarabia-Vallejo, Mario Fuente-Tovar, José Clerigué, Pilar López-Alvarado, Chongzhao Ran, M Antonia Martín, J Carlos Menéndez. (2026). Dioxaborinine-styrylquinoline hybrids as multitarget small-molecule theranostic compounds against Alzheimer's disease.. Bioorganic chemistry. DOI: 10.1016/j.bioorg.2026.110475

Consulta la pubblicazione originale ↗